Perineal Pain
Conditions
Brief summary
Our primary goal will be to investigate the analgesic efficacy of ultrasound (US)-assisted caudal epidural PRF (pulsed radiofrequency)( stimulation in patients with perineal or anal pain cancer patients using (visual analog scale (VAS) scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks; secondary outcomes will be the effects on opioid use and total opioid use in the 24 h, quality of life, patient satisfaction and opioid and intervention related side effects.
Interventions
PROCEDUREUS assisted caudal epidural pulsed radiofrequency
patients will receive US assisted caudal epidural pulsed radiofrequency and followed up to 8 weeks
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* American Society of Anesthesiology physical status of I or III (ASA), of both sex * cancer-related anal or perineal pain
Exclusion criteria
* coagulopathies * allergies to the contrast dye * patients with moderate or significant cardiac/respiratory disease or hepatic
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| visual analog scale (VAS) score 4 weeks post-intervention | 8 weeks | Our primary goal will be to investigate the analgesic efficacy of ultrasound-assisted caudal epidural PRF stimulation in patients with perineal or anal pain cancer patients using VAS scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks |
Countries
Egypt
Outcome results
None listed